US Broker Ratings

Waystar Holding Corp. (WAY) Stock Report: Analysts Signal a Promising 20.51% Upside

Waystar Holding Corp. (WAY), a key player in the healthcare information services industry, has been capturing the attention of individual investors with its promising growth trajectory and robust market position...

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Healthcare Innovator with Strong Buy Ratings Despite Negative P/E

iRhythm Technologies, Inc. (NASDAQ: IRTC) has carved out a notable niche in the healthcare sector, specializing in medical devices that revolutionize cardiac monitoring. With a market capitalization of $4.49 billion,..

Haleon plc (HLN) Stock Analysis: Navigating Market Dynamics with Solid Free Cash Flow

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves in the drug manufacturing space with a market capitalization of $51.09 billion. As a key name in..

ADMA Biologics Inc (ADMA): Unlocking 48.64% Upside Potential with Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA), a leading player in the biotechnology sector, is capturing investor attention with its strong growth trajectory and promising future prospects. Specializing in the development and..

Bruker Corporation (BRKR): Exploring Its 50% Upside Potential and Strategic Position in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR) stands out as a compelling player in the medical devices industry, offering a diverse portfolio of scientific instruments and diagnostic solutions that cater to a broad..

BrightSpring Health Services, I (BTSG) Investor Outlook: Analyzing a Potential 13.97% Upside

BrightSpring Health Services, Inc. (BTSG) has captured investor attention in the healthcare sector with its significant growth potential and robust market presence. Operating as a home and community-based healthcare services..

Prestige Consumer Healthcare (PBH) Stock Analysis: A Healthcare Player with a 3.30% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) has established itself as a notable player in the healthcare sector, focusing on over-the-counter (OTC) health and personal care products. The company’s extensive portfolio..

Sarepta Therapeutics (SRPT) Investor Outlook: Exploring the 139% Potential Upside in Biotech Innovation

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a pioneering force in the biotechnology sector, is making waves in the healthcare industry with its cutting-edge RNA-targeted therapeutics and gene therapies. As the company..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 53.72% Potential Upside

Investors with a keen eye on the healthcare sector, particularly in biotechnology, may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) a compelling investment opportunity. With a market capitalization of $6.11 billion,..

Encompass Health Corporation (EHC) Investor Outlook: Analyzing Growth Potential Amid a Promising 8.58% Upside

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector, boasting a robust market cap of $12.19 billion. As a leading provider of post-acute healthcare services, Encompass Health operates..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 39.92% Potential Upside in the Biotech Sector

Genmab A/S (NASDAQ: GMAB), the Danish biotechnology powerhouse, continues to make waves in the healthcare sector with its innovative antibody-based treatments targeting cancer and other severe diseases. With a market..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Evaluating the 8.89% Dividend Yield Amidst Market Challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a complex player in the healthcare and pharmaceutical retail sector, offering investors a blend of both opportunity and risk. As an established..

BioNTech SE (BNTX) Stock Analysis: Analyst Ratings Favor a 38% Upside Potential

BioNTech SE (NASDAQ: BNTX), a German biotechnology powerhouse, continues to intrigue investors with its innovative approaches to treating cancer and infectious diseases. With a market capitalization of $23.03 billion, this..

Incyte Corporation (INCY) Stock Analysis: Uncovering a 13.56% Potential Upside in Biotech Innovation

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, stands out with its innovative therapeutic offerings and a promising potential upside of 13.56%, making it a compelling consideration..

Zoetis Inc. (ZTS) Stock Report: Analyst Ratings Highlight 15% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector, is making waves in the animal health industry. With a market capitalization of $75.08 billion, Zoetis is a powerhouse..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a 54.54% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) is captivating the attention of investors with a noteworthy potential upside of 54.54%, according to analyst ratings. Positioned in the healthcare sector, this medical..

Ionis Pharmaceuticals (IONS) Stock Analysis: Exploring a 71.71% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is captivating investor interest with its promising pipeline of RNA-targeted medicines and a substantial potential upside of 71.71%...

Molina Healthcare Inc (MOH) Stock Analysis: Exploring an 18.10% Potential Upside in Healthcare Plans

Molina Healthcare Inc (NYSE: MOH) has long been a stalwart in the healthcare plans sector, providing essential managed healthcare services to low-income families and individuals across the United States. With..

Elanco Animal Health (ELAN) Stock Analysis: Assessing the 8.23% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $6.67..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Diagnostics Sector with a 17.19% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $6.66 billion, the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds